The US Food and Drug Administration (FDA) has approved the use of Rybelsus or oral semaglutide to prevent heart attacks and strokes in people living with Type 2 diabetes. This makes it the first oral weight loss drug to be cleared for managing…
US FDA approves first oral weight loss drug to prevent heart attacks, stroke: Doctors break down how Rybelsus works | Health and Wellness News
